Cargando…

Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis

BACKGROUND: Buparvaquone (BPQ), a hydroxynaphthoquinone derivative, has been investigated for the treatment of many infections and is recommended as the gold standard for the treatment of theileriosis. Theileriosis, an intramacrophage infection is localized mainly in reticuloendotheileial system (RE...

Descripción completa

Detalles Bibliográficos
Autores principales: Soni, Maheshkumar P., Shelkar, Nilakash, Gaikwad, Rajiv V., Vanage, Geeta R., Samad, Abdul, Devarajan, Padma V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895290/
https://www.ncbi.nlm.nih.gov/pubmed/24459400
http://dx.doi.org/10.4103/0975-7406.124309
_version_ 1782299955167232000
author Soni, Maheshkumar P.
Shelkar, Nilakash
Gaikwad, Rajiv V.
Vanage, Geeta R.
Samad, Abdul
Devarajan, Padma V.
author_facet Soni, Maheshkumar P.
Shelkar, Nilakash
Gaikwad, Rajiv V.
Vanage, Geeta R.
Samad, Abdul
Devarajan, Padma V.
author_sort Soni, Maheshkumar P.
collection PubMed
description BACKGROUND: Buparvaquone (BPQ), a hydroxynaphthoquinone derivative, has been investigated for the treatment of many infections and is recommended as the gold standard for the treatment of theileriosis. Theileriosis, an intramacrophage infection is localized mainly in reticuloendotheileial system (RES) organs. The present study investigates development of solid lipid nanoparticles (SLN) of BPQ for targeted delivery to the RES. MATERIALS AND METHODS: BPQ SLN was prepared using melt method by adding a molten mixture into aqueous Lutrol F68 solution (80°C). Larger batches were prepared up to 6 g of BPQ with GMS: BPQ, 2:1. SLN of designed size were obtained using ultraturrax and high pressure homogenizer. A freeze and thaw study was used to optimize type and concentration of cryoprotectant with Sf: Mean particle size, Si: Initial particle size <1.3. Differential scanning calorimetry (DSC), powder X-ray diffraction (XRD) and scanning electron microscope (SEM) study was performed on optimized formulation. Formulation was investigated for in vitro serum stability, hemolysis and cell uptake study. Pharmacokinetic and biodistribution study was performed in Holtzman rat. RESULTS: Based on solubility in lipid; glyceryl monostearate (GMS) was selected for preparation of BPQ SLN. Batches of BPQ SLN were optimized for average particle size and entrapment efficiency at <100 mg solid content. A combination of Solutol HS-15 and Lutrol F68 at 2% w/v and greater enabled the desired Sf/Si < 1.3. Differential scanning calorimetry and powder X-ray diffraction revealed decrease in crystallinity of BPQ in BPQ SLN while, scanning electron microscope revealed spherical morphology. BPQ SLN revealed good stability at 4°C and 25°C. Low hemolytic potential (<8%) and in vitro serum stability up to 5 h was observed. Cytotoxicity of SLN to the U937 cell was low. The macrophage cell line revealed high (52%) uptake of BPQ SLN in 1 h suggesting the potential to RES uptake. SLN revealed longer circulation and biodistrbution study confirmed high RES uptake (75%) in RES organs like liver lung spleen etc. CONCLUSION: The high RES uptake suggests BPQ SLN as a promising approach for targeted and improved delivery in theileriosis.
format Online
Article
Text
id pubmed-3895290
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-38952902014-01-23 Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis Soni, Maheshkumar P. Shelkar, Nilakash Gaikwad, Rajiv V. Vanage, Geeta R. Samad, Abdul Devarajan, Padma V. J Pharm Bioallied Sci Original Article BACKGROUND: Buparvaquone (BPQ), a hydroxynaphthoquinone derivative, has been investigated for the treatment of many infections and is recommended as the gold standard for the treatment of theileriosis. Theileriosis, an intramacrophage infection is localized mainly in reticuloendotheileial system (RES) organs. The present study investigates development of solid lipid nanoparticles (SLN) of BPQ for targeted delivery to the RES. MATERIALS AND METHODS: BPQ SLN was prepared using melt method by adding a molten mixture into aqueous Lutrol F68 solution (80°C). Larger batches were prepared up to 6 g of BPQ with GMS: BPQ, 2:1. SLN of designed size were obtained using ultraturrax and high pressure homogenizer. A freeze and thaw study was used to optimize type and concentration of cryoprotectant with Sf: Mean particle size, Si: Initial particle size <1.3. Differential scanning calorimetry (DSC), powder X-ray diffraction (XRD) and scanning electron microscope (SEM) study was performed on optimized formulation. Formulation was investigated for in vitro serum stability, hemolysis and cell uptake study. Pharmacokinetic and biodistribution study was performed in Holtzman rat. RESULTS: Based on solubility in lipid; glyceryl monostearate (GMS) was selected for preparation of BPQ SLN. Batches of BPQ SLN were optimized for average particle size and entrapment efficiency at <100 mg solid content. A combination of Solutol HS-15 and Lutrol F68 at 2% w/v and greater enabled the desired Sf/Si < 1.3. Differential scanning calorimetry and powder X-ray diffraction revealed decrease in crystallinity of BPQ in BPQ SLN while, scanning electron microscope revealed spherical morphology. BPQ SLN revealed good stability at 4°C and 25°C. Low hemolytic potential (<8%) and in vitro serum stability up to 5 h was observed. Cytotoxicity of SLN to the U937 cell was low. The macrophage cell line revealed high (52%) uptake of BPQ SLN in 1 h suggesting the potential to RES uptake. SLN revealed longer circulation and biodistrbution study confirmed high RES uptake (75%) in RES organs like liver lung spleen etc. CONCLUSION: The high RES uptake suggests BPQ SLN as a promising approach for targeted and improved delivery in theileriosis. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC3895290/ /pubmed/24459400 http://dx.doi.org/10.4103/0975-7406.124309 Text en Copyright: © Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Soni, Maheshkumar P.
Shelkar, Nilakash
Gaikwad, Rajiv V.
Vanage, Geeta R.
Samad, Abdul
Devarajan, Padma V.
Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
title Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
title_full Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
title_fullStr Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
title_full_unstemmed Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
title_short Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
title_sort buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895290/
https://www.ncbi.nlm.nih.gov/pubmed/24459400
http://dx.doi.org/10.4103/0975-7406.124309
work_keys_str_mv AT sonimaheshkumarp buparvaquoneloadedsolidlipidnanoparticlesfortargeteddeliveryintheleriosis
AT shelkarnilakash buparvaquoneloadedsolidlipidnanoparticlesfortargeteddeliveryintheleriosis
AT gaikwadrajivv buparvaquoneloadedsolidlipidnanoparticlesfortargeteddeliveryintheleriosis
AT vanagegeetar buparvaquoneloadedsolidlipidnanoparticlesfortargeteddeliveryintheleriosis
AT samadabdul buparvaquoneloadedsolidlipidnanoparticlesfortargeteddeliveryintheleriosis
AT devarajanpadmav buparvaquoneloadedsolidlipidnanoparticlesfortargeteddeliveryintheleriosis